Rad-97 offers Masimo noninvasive and continuous monitoring, through Measure-through Motion and Low Perfusion SET ® pulse oximetry and upgradeable rainbow ® technology, in a compact, standalone monitor ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results